Saturday 17 October 2026
Export NIVF’s income statement to Excel — free account
NewGenIvf Group Limited
NIVF Healthcare Medical Care Facilities
NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.
0.28
0.03
+12.00%
Follow NIVF
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | — |
+3 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
— | 0.00 | — | — | |
Free Cash Flow |
— | (19.60) | — | — | |
Capital Expenditures |
— | (0.35) | — | — | |
| Other line items | |||||
Cash ROIC |
0.00% | (63.54%) | 0.00% | 0.00% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
— | 0.00 | — | — | |
Depreciation/Fixed assets |
0.00 | 0.14 | 0.00 | 0.00 | |
Capex/Depreciation |
— | (0.83) | — | — | |
Operating CF per Share |
— | 0.00 | — | — | |
Capex per Share |
— | 0.00 | — | — | |
Capex to Sales |
— | 0.00 | — | — |
Columns are period end dates · fundamentals updated 9 Oct 2026